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Background: Antegrade cardioplegic delivery may be impaired by coronary
occlusions, whereas retrograde delivery of cardioplegic solution may be
inhomogeneous, leading to an accumulation of lactate and hydrogen ions,
the products of anaerobic metabolism. Integrated cardioplegia using
continuous retrograde cardioplegia and antegrade infusions into completed
vein grafts washes out metabolites accumulated in regions inadequately
perfused by retrograde cardioplegia alone. To determine the flow rates
required to achieve the greatest washout, we compared a high flow rate (200
ml/min) to a low flow rate (100 ml/min). Methods: Twenty patients scheduled
for isolated coronary bypass surgery were prospectively randomized to
compare two flow rates for integrated cardioplegic protection using tepid
(29° C) blood cardioplegia. Arterial and coronary sinus blood samples were
collected to evaluate myocardial metabolism. After antegrade arrest, car-
dioplegic solution was delivered by coronary sinus perfusion and simulta-
neous infusions into each completed vein graft at either high or low flow.
Results: Increasing from low to high flow increased the washout of lactate
and hydrogen ions during the aortic crossclamp period. Two hours after
crossclamp removal, ventricular function was better in the high flow group.
Conclusions: Tepid retrograde cardioplegia resulted in an accumulation of
toxic metabolites. The addition of antegrade vein graft infusions at a flow
rate of 100 ml/min resulted in a washout of these metabolites. A flow rate
of 200 ml/min further improved this washout and resulted in improved
ventricular function. An integrated approach to myocardial protection
using a flow rate of 200 ml/min may improve the results of coronary bypass
surgery. (J Thorac Cardiovasc Surg 1998;115:226-35)
Critical coronary stenoses may limit the delivery ofantegrade cardioplegia to ischemic regions of the
heart, particularly when revascularization with the
internal thoracic artery prevents vein graft infusions
to the left anterior descending coronary artery.
Retrograde delivery of cardioplegic solution
through the coronary sinus has been proposed to be
a superior method of myocardial protection1-3; how-
ever, capillary perfusion may be inadequate.4-7
Hypothermia (10° C) may provide additional pro-
tection but may prevent the resuscitation of the
ischemic myocardium.7 Warm (37° C) blood cardio-
plegia, delivered either antegradely or retrogradely,
permits earlier recovery of ventricular function,8 but
results in greater anaerobic myocardial metabolism.
Interruptions in the delivery of warm blood cardio-
plegia may lead to normothermic myocardial isch-
emia.9 We have recently shown that tepid (29° C)
blood cardioplegia, given either antegradely or ret-
rogradely, reduced anaerobic lactate and acid re-
lease during cardioplegic arrest and preserved ven-
tricular function compared with either warm or cold
cardioplegia.10 However, tepid retrograde cardio-
plegia resulted in a significant accumulation of
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lactate and hydrogen ions, the products of anaerobic
metabolism.
An integrated approach to myocardial protection
with both antegrade and retrograde delivery has been
used to optimize cardioplegic perfusion.11-16 We found
that alternating retrograde perfusion with intermittent
antegrade infusions into the aortic root effectively
washed out lactate and acid that accumulated during
retrograde delivery.14 Retrograde perfusion with si-
multaneous antegrade infusions into each completed
vein graft resulted in similar protection to the alternat-
ing technique and was technically easier.16
We found that increasing normothermic retro-
grade flow rates from 50 to 200 ml/min decreased
anaerobic lactate production.17 Further increases in
flow to 300 or 500 ml/min increased the shunt flow
without decreasing lactate production. This study
was designed to compare delivery of tepid retro-
grade cardioplegia with simultaneous antegrade in-
fusions into completed vein grafts at high flow (200
ml/min) versus low flow (100 ml/min). We hypothe-
sized that tepid retrograde cardioplegia alone would
result in less accumulation of potentially toxic lac-
tate and hydrogen ions than warm retrograde car-
dioplegia. The addition of antegrade vein graft
infusions may wash out any accumulated metabo-
lites, and increasing the flow rate from 100 to 200
ml/min may further improve cardioplegic delivery to
the ischemic myocardium.
Material and methods
Patient population. Twenty patients scheduled for iso-
lated coronary artery bypass grafting by one surgeon
agreed to participate in a study of alternative cardioplegic
techniques. All patients signed a consent form approved
by the Human Experimentation Committee. One patient
in the low flow group was excluded intraoperatively be-
cause of an inability to insert a retrograde coronary sinus
cannula. The preoperative characteristics of the remain-
ing 19 patients are displayed in Table I.
Operative technique. Cardiopulmonary bypass was es-
tablished using an ascending aortic cannula and a single,
two-stage right atrial cannula. During bypass the hemat-
ocrit was between 20% and 25%; pump flows were
between 2.0 and 2.5 L/min per square meter; and the
mean arterial pressure was maintained between 50 and 60
mm Hg, with the administration of sodium nitroprusside
or phenylephrine hydrochloride as required. Systemic
perfusion was not actively cooled or warmed, but the body
temperature was allowed to drift to 34° 6 1° C. Rewarm-
ing to 38° C was begun during the construction of the
proximal anastomoses, which was performed during a
single prolonged crossclamp period. A left internal tho-
racic artery graft was anastomosed to the left anterior
descending coronary artery as the last distal graft in all
patients.
Cardioplegic technique. Patients were randomly as-
signed to either high or low flow cardioplegic delivery
before operation with a computer-generated randomiza-
tion table. All patients received a tepid (29° C) blood
cardioplegic solution that was prepared by mixing four
parts of oxygenated blood with one part of a crystalloid
solution18 and delivered with the Buckberg system (Sorin
Inc., Irvine, Calif.). Cardiac arrest was achieved with an
antegrade infusion of 500 ml of high-potassium (30
mEq/L) cardioplegic solution given at a flow rate between
200 and 400 ml/min sufficient to maintain the aortic root
pressure at 70 mm Hg. After this infusion, the aortic root
was vented and retrograde delivery of cardioplegic solu-
tion began through an autoinflatable coronary sinus can-
nula (Research Medical, Midvale, Utah). Coronary sinus
pressures were monitored continuously by a separate
pressure-monitoring line and maintained at less than 40
mm Hg throughout the procedure. The initial retrograde
flow rate in all patients was 100 ml/min. After completion
of the distal anastamosis of the vein graft to the right
coronary artery, biochemical measurements were ob-
tained at a retrograde flow rate of 100 ml/min. Retrograde
perfusion was then modified to include simultaneous
antegrade infusions into the completed right coronary
artery graft, first at a flow rate of 100 ml/min and then at
200 ml/min in all patients. After a 1-minute timed perfu-
sion at each flow rate, simultaneous retrograde and vein
graft infusions were continued at the flow rate specified by
the randomization table. This protocol discriminated the
effect of retrograde cardioplegia alone, the addition of a
single vein graft at a flow rate of 100 ml/min, and the effect
of increasing the flow rate to 200 ml/min. Timed collec-
tions of the effluent from the aortic root were also
measured as indicated in Fig. 1.
Measurements of myocardial metabolism. Arterial and
coronary sinus blood samples were assayed to estimate the
myocardial consumption of oxygen and production of
lactate or acid. During periods of retrograde perfusion,
effluent from the aortic root was used as a source of
coronary venous blood. Oxygen content (O2Con) was
calculated from the formula:
Table I. Patient demographics
Low flow
(%)
High flow
(%)
p
Value
No. patients 9 10
Age (yr) 61 6 8 58 6 8 0.422
Triple-vessel disease 6 (67) 10 (100) 0.087
Double-vessel disease 3 (33) 0 (0)
LV ejection fraction
.60% 1 (11) 3 (30) 0.326
40%-59% 8 (89) 6 (60)
20%-39% 0 (0) 11 (10)
,20% 0 (0) 0 (0)
Left main disease 0 (0) 2 (20) 0.474
Diabetes mellitus 6 (67) 4 (40) 0.370
Peripheral vascular disease 0 (0) 1 (10) 0.330
Hypertension 4 (44) 4 (40) 0.845
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O2Con 5 1.39 Hgb 3 SaO2 1 0.0031 3 PO2
where Hgb is the hemoglobin concentration, SaO2 is the
oxygen saturation, and PO2 is the partial pressure of
oxygen. Myocardial oxygen extraction (O2Ex) was calcu-
lated as the arterial or cardioplegic oxygen content minus
the coronary effluent oxygen content and myocardial
oxygen consumption (MVO2) determined after correcting
for coronary flow (MVO2 5 O2Ex 3 flow). Measurements
were made at 37° C and then corrected to the cardioplegic
temperature at the time of sampling.
Blood lactate concentration was determined with the use
of a commercially available assay (Rapid Lactate Stat Pack
kit, Calbiochem-Behring, La Jolla, Calif.). Lactate extraction
(LEx) was calculated as the difference between arterial and
coronary effluent lactate content. Negative lactate extraction
is expressed as net lactate release. Lactate consumption or
production (MVL) was determined after correcting lactate
extraction for coronary flow.
The concentration of hydrogen ion [H1] in blood was
determined by converting the measured pH value to [H1]
by the formula: [H1] 5 Antilog (–pH). Measurements
were made at 37° C and corrected to the myocardial
temperature at the time of sampling. Myocardial acid
production was calculated as the difference in H1 concen-
tration between arterial and coronary effluent blood cor-
rected for coronary flow.
Creatine kinase measurement. An antibody inhibition
technique was used to measure the MB isozyme of
creatine kinase (CK-MB). Sequential CK-MB measure-
ments were performed at 2, 4, 8, 16, 24, and 48 hours after
the removal of the aortic crossclamp. Integration of the
area under the concentration-time curve for CK-MB
within the first 48 hours postoperatively allowed calcula-
tion of the total CK-MB release, expressed as units
(IU3hr). We have previously found that this assessment
correlates with infarction as assessed by technetium pyro-
phosphate scan.19
Hemodynamic measurements. Heart rate, mean arte-
rial pressure, and mean pulmonary artery pressure were
measured preoperatively and postoperatively. Cardiac
output was measured in triplicate via a thermodilution
technique by an independent individual who was unaware
of the cardioplegic technique used. Derived hemodynamic
indices were calculated:
CI 5 CO/BSA ~L/min/m2!
SI 5 CI/HR ~ml/min/m2!
LVSWI 5 SI 3 ~MAP – PCWP! 3 0.0316 ~gm z m/m2!
SVRI 5 ~MAP – RAP! 3 80/CI ~dyne z sec/cm5!
Fig. 1. Study protocol for comparing flow rates. After antegrade arrest by way of the aortic root,
continuous retrograde delivery was instituted through the coronary sinus at a flow rate of 100 ml/min.
Cardioplegic flow was interrupted whenever necessary to visualize the distal anastomosis. After completion
of the first distal anastomosis, the cardioplegic solution was delivered both retrogradely and antegradely
into the vein graft at a flow rate of 100 ml/min for 1 minute, then at 200 ml/min for 1 minute. Simultaneous
antegrade and retrograde delivery of the cardioplegic solution was then given at either low (100 ml/min)
or high (200 ml/min) flow for the remainder of the procedure. XCL, Aortic crossclamp; CPB, cardiopul-
monary bypass; LITA, left internal thoracic artery.
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where CI 5 cardiac index, BSA 5 body surface area, SI 5
stroke index, LVSWI 5 left ventricular stroke work index,
and SVRI 5 systemic vascular resistance index.
These hemodynamic variables were measured before
initiation of cardiopulmonary bypass and at 2, 4, 8, and 24
hours after removal of the aortic crossclamp. Postopera-
tive preload and afterload were optimized by individuals
who were unaware of the cardioplegic technique used.20
Statistical analysis. Statistical analysis was performed
using the SAS program (SAS Institute, Cary, N.C.).
Categorical variables were analyzed with x2 or Fisher’s
exact test as appropriate. Continuous variables were ana-
lyzed using analysis of variance (ANOVA) or paired t tests
as appropriate. A two-way ANOVA was used to simulta-
neously evaluate the effect of time and flow rate between
groups. When the F statistic of the two-way ANOVA was
significant, differences between groups were specified by
Duncan’s multiple range test. Statistical significance was
assumed at p , 0.05.
Results
Table II presents the operative data. No signifi-
cant differences were found in the number of grafts
constructed, the aortic crossclamp time, or the total
cardiopulmonary bypass time. All 10 patients in the
high flow group received an initial saphenous vein
graft to the right coronary artery or one of its
branches compared with eight of nine patients in the
low flow group. Despite an increased flow rate in the
high flow group, the total volume of cardioplegic
solution delivered did not differ between groups
(p 5 0.749). Similarly, the volume of effluent in the
aortic root measured during the last 1-minute timed
collection was not different between groups. The
volume of effluent in the aortic root did not increase
significantly when the flow rate was increased to 200
ml/min (low 85 6 19 ml vs high 116 6 45 ml, p 5
0.217). When the volume of cardioplegic solution
delivered was adjusted for the aortic crossclamp
time, total cardioplegic delivery was higher in the
high flow group (114 6 22 ml/min vs low 84 6 18
ml/min, p 5 0.005). Similarly, cardioplegic delivery
per bypass graft was also higher in the high flow
group (1677 6 365 ml/graft vs low 1264 6 239
ml/graft, p 5 0.01). Ischemic time expressed as the
percentage of the crossclamp period during which
no cardioplegic solution was given was not different
between groups. Minimum cardioplegic tempera-
tures were similar in both groups (low 34° 6 0.5° C
vs high 35° 6 0.1° C, p 5 0.616 by two-way
ANOVA).
No deaths, strokes, or perioperative myocardial
infarctions occurred in this low-risk study popula-
tion. One patient in the high flow group had low
cardiac output syndrome because he required ino-
tropic support for greater than 30 minutes in the
intensive care unit to maintain systolic blood pres-
sure greater than 90 mm Hg and a cardiac index of
2.1 L/min per square meter or greater. Perioperative
myocardial injury estimated by the area under the
CK-MB curve was not different between groups.
Metabolic data. Myocardial oxygen consump-
tion, lactate, and acid production were similar in
both groups after antegrade arrest. Table III illus-
trates myocardial oxygen extraction, lactate, and
acid release before aortic crossclamping, after ante-
grade arrest, during the first retrograde dose (at a
flow rate of 100 ml/min), and during reperfusion. No
differences were demonstrated between groups.
Fig. 2 illustrates the change in myocardial oxygen
consumption, lactate, and acid production after the
completion of the right coronary artery graft. Tepid
retrograde cardioplegia alone resulted in an accu-
mulation of hydrogen ions that was washed out after
the addition of simultaneous antegrade perfusion
into the right coronary artery graft. Increasing the
flow rate from 100 ml/min to 200 ml/min resulted in
a further washout of lactate and hydrogen ions with
a corresponding increase in myocardial oxygen con-
sumption.
During the crossclamp period, high cardioplegic
flows resulted in greater lactate release. Similarly,
myocardial acid release was higher in the high flow
Table II. Operative data
Low flow
(n 5 9)
High flow
(n 5 10) p Value
LIMA 9 (100%) 10 (100%) 1.000
Grafts
Three 2 (22%) 0 (0%) 0.198
Four 2 (22%) 5 (50%)
Five 5 (56%) 5 (50%)
Pump time (min) 86 6 15 85 6 12 0.862
Crossclamp time (min) 66 6 13 66 6 12 0.989
Total cardioplegic so-
lution delivered (ml)
5168 6 1314 5550 6 2879 0.749
Average cardioplegic
return in aortic root
(ml/min)
82 6 20 89 6 48 0.655
Percentage of cross-
clamp time without
cardioplegia
31 6 6 33 6 9 0.544
Area under the
CKMB curve
(IU z hr)
1747 6 724 1331 6 1198 0.475
Myocardial infarction 0 0 1.000
Low-output syndrome 0 1 0.330
Stroke 0 0 1.000
Operative mortality 0 0 1.000
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group. Acid washout decreased throughout the
crossclamp period, resulting in no significant differ-
ences between groups after completion of the fourth
distal anastomosis. Similarly, myocardial oxygen
consumption was higher in the high flow group, but
this difference dissipated as additional vein grafts
became perfused. Fig. 3 illustrates the difference in
metabolite washout between the two groups.
Hemodynamic data. Postoperative heart rate was
increased compared with baseline, whereas the
mean arterial pressure fell, but no differences were
found between groups in heart rate or mean arterial
pressure either before or after surgery. Fig. 4 dis-
plays the postoperative hemodynamic data obtained
at 2, 4, 8, and 24 hours after the removal of the
aortic crossclamp. Cardiac index and left ventricular
stroke work index were higher in the high flow group
2 hours postoperatively at similar filling pressures
(p , 0.05 by analysis of covariance [ANOCOVA]).
Discussion
Despite apparently adequate blood cardioplegic
protection, sensitive measures reveal delayed recov-
ery of myocardial metabolism and ventricular func-
tion.7, 8 This impairment may be due to inhomoge-
neous distribution of cardioplegic solution during
either antegrade or retrograde cardioplegia alone.21
An integrated cardioplegic technique using both
antegrade and retrograde delivery has been advo-
cated by many authors.11-16 However, the optimal
flow rate required to improve myocardial perfusion
when using integrated cardioplegia is not known.
We previously found that a flow rate of less than 200
ml/min during normothermic (37° C) retrograde
cardioplegia resulted in an accumulation of lactate
and acid during the crossclamp period.17 Flow rates
in excess of 200 ml/min did not result in further
washout of toxic metabolites. However, flow rates of
200 ml/min may be detrimental if they result in high
coronary sinus pressures. A coronary sinus pressure
of greater than 40 mm Hg has been reported to
result in perivascular hemorrhage and edema, as
well as direct coronary sinus injury.22
Lowering the temperature from 37° C to 29° C
reduced myocardial oxygen consumption by almost
50%.10 Therefore a 50% reduction in flow rate from
Table III. Perioperative metabolic data
Low flow
(n 5 9)
High flow
(n 5 10) p Value
Baseline
Oxygen extraction (dl/ml) 2.9 (0.5) 3.1 (0.5) 0.836
Lactate extraction (mmol/ml) 20.3 (0.3) 0.2 (0.1) 0.139
Acid release (D pH) 0.05 (0.01) 0.06 (0.01) 0.561
Antegrade arrest
Oxygen extraction (dl/ml) 3.0 (0.7) 2.6 (0.4) 0.638
Lactate extraction (mmol/ml) 20.1 (0.2) 20.1 (0.2) 0.982
Acid release (D pH) 0.09 (0.03) 0.12 (0.02) 0.310
Initial retrograde (100 ml/min)
Oxygen extraction (dl/ml) 0.3 (0.1) 0.2 (0.1) 0.665
Lactate extraction (mmol/ml) 20.3 (0.2) 20.6 (0.1) 0.187
Acid release (D pH) 0.01 (0.01) 0.05 (0.01) 0.003
Retrograde and first vein graft (100 ml/min)
Oxygen extraction (dl/ml) 0.4 (0.4) 0.4 (0.4) .522
Lactate extraction (mmol/ml) 20.6 (0.3) 20.8 (0.3) .628
Acid release (D pH) 0.08 (0.01) 0.08 (0.01) .961
Aortic crossclamp removal
Oxygen extraction (dl/ml) 1.2 (0.3) 2.0 (0.5) 0.213
Lactate extraction (mmol/ml) 0.1 (0.1) 20.2 (0.1) 0.144
Acid release (D pH) 0.03 (0.01) 0.05 (0.01) 0.317
Reperfusion (5 min)
Oxygen extraction (dl/ml) 3.9 (0.5) 4.2 (0.5) 0.761
Lactate extraction (mmol/ml) 20.1 (0.1) 20.1 (0.1) 0.522
Acid release (D pH) 0.06 (0.01) 0.07 (0.01) 0.642
Reperfusion (10 min)
Oxygen extraction (dl/ml) 5.5 (0.5) 5.0 (0.4) 0.466
Lactate extraction (mmol/ml) 0.1 (0.1) 0.1 (0.1) 0.991
Acid release (D pH) 0.05 (0.01) 0.07 (0.01) 0.148
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200 ml/min to 100 ml/min may not be detrimental at
a myocardial temperature of 29° C. This study was
undertaken to determine the optimal flow rate for
integrated tepid (29° C) blood cardioplegia and is
the first report to investigate flow rates with this
increasingly popular cardioplegic technique.
At 29° C, retrograde flows of 100 ml/min were
inadequate to maintain homogeneous myocardial
perfusion. The addition of a single vein graft
resulted in increased washout of lactate and acid.
Most patients (18 of 19) received an initial graft to
the right coronary artery or one of its distal
branches. Increasing the flow rate from 100 to 200
ml/min resulted in a further washout of toxic
metabolites. We believe that the increased flow
rate led to improved myocardial perfusion. When
perfusion was improved by additional antegrade
infusions into completed vein grafts, the effect of
flow rate was attenuated. Thus anaerobic metab-
olism was stimulated by inadequate myocardial
perfusion that was prevented by either increasing
the flow rates or by the addition of simultaneous
vein graft infusions.
We were able to deliver a flow rate of 200 ml/min
in all 10 patients in the high flow group with a
coronary sinus pressure less than 40 mm Hg. We
used a single pump head to deliver cardioplegic
solution into the coronary sinus cannula and the
vein grafts simultaneously. Possibly, increases in
coronary sinus pressure may have resulted in in-
creased flow down the vein grafts. It is also possible
that higher flow rates (in excess of 250 ml/min) may
be better than our high-flow technique. We did not
examine this possibility in our study. We did find,
however, that the effluent in the aortic root during a
1-minute timed collection was not different between
groups. The variability in this measurement likely
reflects the variability in thebesian shunt flow. Thus
increasing flow rates beyond 200 ml/min during
integrated cardioplegic delivery may increase the
shunt fraction as we observed with retrograde car-
dioplegia alone.17
Fig. 2. Top panel, Percent change in lactate and acid production and oxygen consumption after the
addition of antegrade cardioplegic perfusion into the completed right coronary artery graft. Bottom panel,
Percent change in lactate and acid production and oxygen consumption achieved by increasing the flow rate
from 100 ml/min (low) to 200 ml/min (high). Myocardial oxygen consumption significantly increased as the
flow rate increased. Similarly, increasing the cardioplegic flow rate significantly increased lactate and acid
washout.
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The improved myocardial perfusion in the high
flow group improved early postoperative hemody-
namics. Fig. 4 illustrates that at a given preload (left
ventricular end-diastolic pressure), cardiac index
and left ventricular stroke work index were higher in
the high flow group. No differences were observed
between groups in clinical outcomes. Our study
population consisted of low-risk patients with excel-
Fig. 3. Panel A, Myocardial lactate release after completion of each distal anastomosis. Washout of
accumulated lactate was higher in patients receiving high cardioplegic flow rates after the second distal
anastomosis. The difference between high and low flow rates dissipated as additional vein grafts became
perfused (p 5 0.088 by two-way ANOVA). Panel B, Myocardial oxygen consumption after completion of
each distal anastomosis. Oxygen consumption was higher in patients receiving high cardioplegic flow rates
after the first distal anastomosis. This difference dissipated as additional vein grafts became perfused (p 5
0.158 by two-way ANOVA). Panel C, Myocardial acid release after completion of each distal anastomosis.
Washout of accumulated hydrogen ions was higher in patients receiving high cardioplegic flow rates (p 5
0.034 by two-way ANOVA) (mean 6 standard error of the mean).
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lent collateral circulation and preserved left ventric-
ular function, and clinical differences were not an-
ticipated.
Study limitations. Coronary venous blood ob-
tained from the aortic root during retrograde deliv-
ery of cardioplegic solution is contaminated by
noncoronary collateral blood flow from the pulmo-
nary veins. Contamination is further exacerbated by
simultaneous vein graft perfusions that may deliver
oxygenated blood cardioplegic solution into the
aortic effluent. These sources of contamination tend
to decrease both lactate and acid concentrations
while increasing oxygen tensions in the aortic efflu-
ent. Therefore our measurements of myocardial
washout underestimate the true accumulation of
lactate and acid in ischemic myocardium. Coronary
blood flow during cardioplegic arrest was assumed
to be equivalent to cardioplegic flow rate. Variabil-
ity in the thebesian shunt fraction at different flow
rates also confounds these measurements.
Fig. 4. Panel A, Cardiac index at baseline (PRE), 2, 4, 8, and 24 hours postoperatively. Cardiac index was
greater in the high flow group (hollow symbols; p 5 0.03 by ANOCOVA). LVEDP, Left ventricular
end-diastolic pressure (mm Hg). Panel B, Left ventricular stroke work index (LVSWI) at baseline (PRE),
2, 4, 8, and 24 hours postoperatively. LVSWI was greater in the high flow group (hollow symbols; p 5 0.05
by ANOCOVA). PCWP, Pulmonary capillary wedge pressure (mm Hg).
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Despite these limitations, we were able to detect
subtle differences in myocardial metabolism during
cardioplegic arrest. Our ability to detect differences
in metabolite washout despite significant contami-
nation suggests an even larger difference between
high- and low-flow groups. Furthermore, the signif-
icant improvement in left ventricular function 2
hours after crossclamp removal suggests that im-
proved myocardial protection was achieved at
higher flow rates.
Coronary blood flow was not measured during
reperfusion. Therefore our inability to detect meta-
bolic differences during reperfusion may be a result
of differences in coronary blood flow that may have
masked true differences in metabolic activity.
Our technique of “continuous” retrograde de-
livery of blood cardioplegic solution required
interruption for more than 30% of the crossclamp
period to adequately visualize the distal anasto-
mosis. Maintaining “continuous” flow throughout
the crossclamp period may have reduced the
accumulation of toxic metabolites that we ob-
served in this study. However, we believe that is
more prudent to ensure a technically proficient
distal anastomosis and continue to interrupt car-
dioplegic delivery whenever necessary. When in-
terruptions are necessary, a flow rate of 200
ml/min is required to ensure adequate washout of
the accumulated metabolites.
Summary
We conclude from this study that flow rates of
100 ml/min are inadequate when using an inte-
grated, tepid blood cardioplegic approach to myo-
cardial protection. We have previously demon-
strated that subtle metabolic and hemodynamic
differences of the magnitude found in this study
correlate with differences in clinical outcomes in
higher risk populations, such as those patients
who require surgery for unstable angina.23, 24
Therefore in high-risk patients flow rates less than
200 ml/min may increase the incidence of postop-
erative morbidity and mortality. The possible ben-
efits of increasing flow rates beyond 250 ml/min
requires further investigation.
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